|2022/08/25 / Erste Group Research|
Health Care stocks with stable growth
Rating changes: Costco Wholesale, Merck & Co, Abbott Laboratories, Schneider Electric
The US Purchasing Managers' Index weakened for the second time in succession. It last stood at 45 points. This confirms that the contraction in economic activity in the USA is continuing. In Europe, the composite purchasing managers' index also deteriorated most recently. At a level of 49.2 points, this leading indicator for Europe also shows that a weakening of the economy is taking place.
The global stock market reacted to the weakening of global economic indicators with slight declines and an increase in volatility. Now that the reporting season is almost over, economic and political aspects will once again increasingly come to the attention of investors in the coming weeks. Corporate earnings growth forecasts are stable for 2022 (2022e earnings: +7.0%). We expect the global stock market index to trend sideways in the coming weeks.
Merck & Co: Successful products for immunotherapy against cancer
AMD: High sales growth in 2Q but very sharp increase in operating costs
Royal Bank of Canada: Net interest income up, income from commissions and fees down
Download PDF (5.6MB)
|Author||Erste Group Research|
|Product name||Recommendation List|
|Topic in focus||Equities|
|Economy in focus||Eurozone, Germany, United Kingdom, United States|
|Currency in focus||British Pound, Euro, US Dollar|
|Sector in focus||Automobiles & Parts, Banks, Basic Resources, Chemicals, Construction & Material, Financial Services, Food & Beverage, Health Care, Industrial Goods & Services, Insurance, Media, Oil & Gas, Personal & Household Goods, Retail, Technology, Telecommunications, Travel & Leisure, Utilities|
|Name||ISIN||# Erste Group products|
|Vestas Wind Systems||DK0010268606||0|
Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.
By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer